AstraZeneca
hideAstraZeneca plc (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
For more information about AstraZeneca, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with astrazeneca
Newer Anti-Clotting Medication Found to Be More Effective
Medicine & Health / Medications
Aug 30, 2009 |
4 / 5 (2) |
0
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Study shows experimental drug cuts stroke risk
Medicine & Health / Medications
Aug 30, 2009 |
5 / 5 (1) |
0
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Project Zero Delay accelerates drug's path to clinical trial
Aug 03, 2009 |
not rated yet |
0
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six ...
FDA weighs approval of psychiatric drugs for kids
Medicine & Health / Medications
Jun 05, 2009 |
3 / 5 (2) |
3
(AP) -- Three blockbuster psychiatric drugs currently approved for adults also appear to work in adolescents, though federal health officials have concerns about exposing younger patients to the drugs' side effects.
Abbott, AstraZeneca seek cholesterol pill approval
Medicine & Health / Medications
Jun 04, 2009 |
4 / 5 (1) |
0
(AP) -- Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.
AstraZeneca, Merck collaborate on cancer treatment
Jun 01, 2009 |
not rated yet |
0
(AP) -- AstraZeneca PLC and Merck & Co. said Monday they will jointly develop a pair of drugs meant to hit cancer with a one-two punch, part of a growing trend of combination cancer treatments.
AstraZeneca e-mails show debate on Seroquel risks
Medicine & Health / Medications
May 20, 2009 |
not rated yet |
0
(AP) -- Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm ...
Research sheds new light on inflammatory disease
Apr 09, 2009 |
5 / 5 (4) |
0
Scientists at the University of Liverpool have found that understanding the precise timing of communication between cells that coordinate the body's response to disease could be key to new drug developments.
